ImmunoBrain Checkpoint appoints Dr. Sanjay Keswani as CEO
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Collaboration streamlines patient access to oncology clinical trials
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
Inducts advanced AI-Powered 24x7 remote patient monitoring system
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Subscribe To Our Newsletter & Stay Updated